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Abamectin (ABA), which belongs to the family of avermectins, is used as a parasiticide; however, ABA poi-
soning can impair liver function. In a previous study using isolated rat liver mitochondria, we observed
that ABA inhibited the activity of adenine nucleotide translocator and FoF1-ATPase. The aim of this study
was to characterize the mechanism of ABA toxicity in isolated rat hepatocytes and to evaluate whether
this effect is dependent on its metabolism. The toxicity of ABA was assessed by monitoring oxygen con-
sumption and mitochondrial membrane potential, intracellular ATP concentration, cell viability, intracel-
lular Ca2+ homeostasis, release of cytochrome c, caspase 3 activity and necrotic cell death. ABA reduces
cellular respiration in cells energized with glutamate and malate or succinate. The hepatocytes that were
previously incubated with proadifen, a cytochrome P450 inhibitor, are more sensitive to the compound as
observed by a rapid decrease in the mitochondrial membrane potential accompanied by reductions in
ATP concentration and cell viability and a disruption of intracellular Ca2+ homeostasis followed by necro-
sis. Our results indicate that ABA biotransformation reduces its toxicity, and its toxic action is related to
the inhibition of mitochondrial activity, which leads to decreased synthesis of ATP followed by cell death.
2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Avermectins are metabolites derived from the fermentation of
the fungi Streptomyces avermitilis; these metabolites belong to
the family of macrocyclic lactones and exhibit extraordinarily po-
tent anthelmintic activity (Burg et al., 1979; Fisher and Mrozik,
1989). Abamectin (ABA) is a mixture of avermectins containing
P80% B1a and 620% B1b (Meister, 1992; Zeng et al., 1996; Agarwal,
1998). Avermectin B1a and B1b differ chemically by the presence of
a methylene or ethylene group at C-26 (Zeng et al., 1996). Accord-
ing to Hayes and Laws (1990), these molecules have similar biolog-
ical activities and toxicological properties. ABA is widely used
because of its potent anthelmintic and insecticidal action and wide
spectrum of action. ABA is also used as an insecticide to control cit-
rus, nut culture and household pests, such as ﬁre ants (Elbetieha
and Daas, 2003). In veterinary medicine, ABA is administered to
animals in a systematic way to control endoparasites and ectopar-
asites (Shoop et al., 1995).
The mechanism of ABA action is related to its effect on the
c-aminobutyric acid (GABA) system and Cl channels. GABA recep-
tors are responsible for regulating the neural basal tone of thex: +55 18 3821 8208.
Mingatto).
er OA license.brain (Turner and Schaeffer, 1989) and are in virtually all neurons
of the central nervous system (CNS). The symptoms of ABA poison-
ing exhibited in laboratory animals include pupil dilation, vomit-
ing, convulsions and/or tremors and coma (Lankas and Gordon,
1989). In addition, some studies have reported genotoxic effects
of ABA (Molinari et al., 2010).
As demonstrated by the in vivo studies (Lowenstein et al., 1996;
Hsu et al., 2001) and the in vitro study conducted with isolated
hepatocytes (El-Shenawy, 2010), the liver can also be affected by
ABA. ABA caused an increase in the concentration of the enzyme
aspartate aminotransferase (AST) in serum in vivo and an increase
in the concentration of AST and alanine aminotransferase (ALT)
in vitro, which are used as indicators of damage to the hepatic
parenchymal cells (Klaassen and Eaton, 1991). We previously dem-
onstrated that ABA inhibits the activity of FoF1-ATPase and adenine
nucleotide translocator (ANT) when added at micromolar concen-
trations to isolated rat liver mitochondria, an effect associated with
signiﬁcantly reduced ATP synthesis (Castanha Zanoli et al., 2012).
FoF1-ATPase is an enzyme present in the inner mitochondrial
membrane that is responsible by ATP synthesis driven by the pro-
ton electrochemical gradient generated in the respiratory chain.
The main components of the enzyme are Fo, an integral membrane
protein that works as a proton channel, and F1, a hydrophilic
moiety which contains the catalytic and regulatory sites (Hateﬁ,
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mitochondrial machinery of ATP synthesis because of its intrinsic
adenine nucleotide translocase activity. ANT has been involved in
both pathological (mitochondrial permeability transition forma-
tion/regulation and cell death) and physiological (adenine nucleo-
tide exchange) mitochondrial events, making it a prime target for
drug-induced toxicity (Oliveira and Wallace, 2006).
The xenobiotic metabolism in the liver is accomplished by cyto-
chrome P450 and its main function is to increase the polarity of
these substances, so excretion occurs more easily (Oga, 2008).
However, this process is responsible for the toxic effects of numer-
ous chemical compounds. The metabolites may cause adverse ef-
fects in the animal (Ioannides and Lewis, 2004; Mingatto et al.,
2007; Maioli et al., 2011) by changing a fundamental cellular com-
ponent (mitochondria, for example) at the cellular and molecular
level, thus modulating its function (Meyer and Kulkarni, 2001).
Due to the important functions of the liver in animals and pre-
vious studies that indicated the occurrence of liver damage after
the use of ABA, this study aims to characterize the mechanisms
of ABA toxicity on parameters related to bioenergetics and cell
death and determine whether the toxicity induced by the com-
pound is due to a possible activation following its metabolism in
the liver.2. Materials and methods
2.1. Chemicals
Abamectin, containing 92% avermectin B1a and 8% avermectin
B1b, was kindly supplied by the company Ouroﬁno Agribusiness
(Cravinhos, SP, Brazil), proadifen was purchased from Sigma–
Aldrich (St. Louis, MO, USA), and sodium pentobarbital was a gift
from Cristália (Itapira, SP, Brazil). All other reagents were of the
highest commercially available grade. Abamectin and proadifen
were dissolved in anhydrous dimethyl sulfoxide (DMSO). All stock
solutions were prepared using glass-distilled deionized water.
2.2. Animals
Male Wistar rats aged 7–8 weeks and weighing approximately
200 g, were used in this study. The animals, which were obtained
from the Central Bioterium of UNESP – Univ Estadual Paulista,
Campus de Botucatu, SP, Brazil, were maintained with a maximum
of 4 rats per cage under standard laboratory conditions with water
and food provided ad libitum. The experimental protocols were ap-
proved by the Ethical Committee for the Use of Laboratory Animals
of the UNESP – Univ Estadual Paulista, Campus de Dracena, SP,
Brazil.
2.3. Isolation and incubation of hepatocytes
For the surgical procedure, the rats were anesthetized by an
intraperitoneal injection of sodium pentobarbital (50 mg/kg body
weight). The hepatocytes were isolated by a collagenase perfusion
of the liver as described previously (Guguen-Guillouzo, 1992). The
hepatocyte viability after isolation was determined by Trypan blue
(0.16%) uptake, and the initial cell viability in all experiments was
more than 85%. The hepatocytes were suspended in Krebs-Hense-
leit buffer, pH 7.4, containing 12.5 mM Hepes and 0.1% bovine ser-
um albumin (BSA), and maintained at 4 C. The cells (1  106/mL)
were incubated in 25-mL Erlenmeyer ﬂasks, which were main-
tained under constant agitation (30 rpm) at 37 C under a 95% O2
and 5% CO2 atmosphere. The reactions in the experiments of cell
viability, cellular ATP content, mitochondrial membrane potential,
release of cytochrome c, caspase 3 activity and necrotic cell deathwere initiated by the addition of abamectin (ABA) at concentra-
tions of 25, 50, 75 and 100 lM. Aliquots (1 mL) of the suspension
were removed from the mixture at appropriate times for the deter-
mination of cell death and biochemical parameters. In some exper-
iments, the cells were incubated with 100 lM proadifen 15 min
before the addition of ABA.
2.4. Oxygen uptake
Oxygen uptake by the isolated hepatocytes was monitored
using a Clark-type oxygen electrode (Strathkelvin Instruments
Limited, Glasgow, Scotland, UK). The respiration buffer contained
250 mM sucrose, 2 mM KH2PO4, 10 mM HEPES, pH 7.2, 0.5 mM
EGTA, 0.5% BSA, and 5 mM MgCl2, at 37 C. The cells were treated
with 0.002% digitonin, and state 4 and state 3 mitochondrial respi-
ration rates were measured in the presence of 1 lg/mL oligomycin
and 2 mM ADP, respectively (Moreadith and Fisckum, 1984). ABA
at concentrations of 5, 10, 15 and 25 lMwas added to the medium
immediately after the initiation of state 3 or state 4 respirations.
2.5. Mitochondrial membrane potential
The mitochondrial membrane potential was determined using
the ﬂuorescent probe TMRM (tetramethyrodamine, methyl ester).
The cell suspensions incubated with different concentrations of
abamectin were collected and centrifuged at 50g for 5 min. The
pellet was suspended and incubated for 10 min at 37 C with
TMRM solution at a ﬁnal concentration of 6.6 lM. After the incuba-
tion, the samples were centrifuged twice at 50g for 5 min, and the
pellet was suspended with 1 ml of Triton X-100, 0.1% (v/v). Subse-
quently, the samples were centrifuged at 2000g for 5 min, and the
ﬂuorescence of the TMRM captured and retained by the mitochon-
dria was determined in the supernatant using a ﬂuorescence spec-
trophotometer RF-5301 PC (Shimadzu, Tokyo, Japan) at excitation
and emission wavelengths of 485 and 590 nm, respectively. The re-
sults are expressed as a percentage of the ﬂuorescence intensity
over the control group.
2.6. Cellular ATP content
Cellular ATP content was determined by the ﬁreﬂy luciferin–
luciferase assay. The cell suspension was centrifuged at 50g for
5 min at 4 C, and the pellet containing the hepatocytes was trea-
ted with 1 mL of ice-cold 1 M HClO4. After centrifugation at
2000g for 10 min at 4 C, aliquots (100 lL) of the supernatant were
neutralized with 65 lL of 2 M KOH, suspended in 100 mM
Tris–HCl, pH 7.8 (1 mL ﬁnal volume), and centrifuged again. Biolu-
minescence was measured in the supernatant with a Sigma–
Aldrich assay kit according to the manufacturer’s instructions
using a SIRIUS Luminometer (Berthold, Pforzheim, Germany).
2.7. Evaluation of cell viability
Cell viability was assessed by the leakage of alanine transami-
nase (ALT) and aspartate transaminase (AST) from hepatocytes.
After incubation with ABA at concentrations of 25, 50, 75 and
100 lM the cell suspensions were collected at time 0, 30, 60, 90
and 120 min and centrifuged (50g for 5 min). The presence of
ALT and AST in the supernatant was determined using Enzyme
Activity Assay Kits (Bioclin, Quibasa, Brazil) according to the man-
ufacturer’s instructions. The absorbance was measured at 340 nm
with a spectrophotometer DU-800 (Beckman Coulter, Fullerton,
CA, USA). Enzyme activity in the supernatant is expressed as a per-
centage of the total activity, which was determined by lysing the
cells with 0.5% Triton X-100.
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Fig. 1. Effects of abamectin (ABA) on glutamate-plus-malate-supported (A) or
succinate-supported (B) state 3 (ADP stimulated) respiration of mitochondria in
digitonin-permeabilized isolated rat hepatocytes. The ﬁgure is representative of ﬁve
experiments with different cell preparations. ⁄,⁄⁄Signiﬁcantly different from the
control (without ABA) (P < 0.05 and P < 0.01, respectively).
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Hepatocytes (2  106/ml) were incubated in Krebs-Henseleit
medium supplemented with 2% BSA, 12.5 mM HEPES and 10 mM
glucose, pH 7.4. In this medium, 0.005% pluronic acid and 5 lM
Fura-2 acetoxymethyl ester (Fura-2 AM) were added. The0 30 60 90 120
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Fig. 2. Effects of abamectin (ABA) on the mitochondrial membrane potential assessed by
isolated rat hepatocytes (106 cells/ml) in the absence or presence of 100 lM proadifen
preparations. ##Signiﬁcantly different from control (without ABA) at the correspon
corresponding time (P < 0.05 and P < 0.01, respectively).hepatocytes were maintained under constant agitation at 32 C
for 60 min to capture the probe.
The cell suspension loaded with Fura-2 AM was collected and
subjected to two centrifugations at 50g for 3 min to remove resid-
ual Fura-2 AM and maintained at 4 C for later use. The ﬂuores-
cence of Ca2+ was determined by the ratio of the excitation
wavelengths at 340 and 380 nm and emission wavelength at
505 nm using the ﬂuorescence spectrophotometer RF-5301 PC
(Shimadzu, Tokyo, Japan). The calibration and calculations in
[Ca2+]c were performed as previously described (Grynkiewicz
et al., 1985). Maximum ﬂuorescence (Fmax) was obtained by the
addition of 1% Triton X-100, and minimum ﬂuorescence (Fmin)
was obtained by the addition of 10 mM EGTA. The equilibrium con-
stant for the calculations was 225 nM. Changes in free [Ca2+]c in the
cytoplasm of hepatocytes were evaluated with increasing addi-
tions of ABA (25, 50, 75 and 100 lM) every 300 s.2.9. Release of cytochrome c
The release of cytochrome c was determined as previously de-
scribed (Appaix et al., 2000). The hepatocytes (2.7 mg protein/ml)
were incubated in Krebs-Henseleit medium supplemented with
BSA (2 mg/mL), 0.002% digitonin and different concentrations of
abamectin at 25 C for 30 min. After the incubation, the cells were
centrifuged at 10,000g for 30 min at 4 C, and the supernatant was
collected and ﬁltered through a 0.2 lm Millipore membrane. The
absorbance was determined in a spectrophotometer DU-800
(Beckman Coulter, Fullerton, CA, USA) by the difference in absor-
bance at wavelengths 414 and 600 nm. The results are expressed
in nmol cytochrome c released/106 cells using a molar extinction
coefﬁcient (e) of 100 mM1 cm1.2.10. Caspase 3 activity
The assessment of caspase 3 activity was performed using a
Caspase 3 assay kit (Sigma–Aldrich). The hepatocytes were0 30 60 90 120
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Fig. 3. Effects of abamectin (ABA) on the intracellular concentration of ATP in isolated rat hepatocytes (106 cells/ml) in the absence or presence of 100 lM proadifen (P). The
results represent the mean ± SEM of ﬁve different cell preparations. #,##Signiﬁcantly different from control (without ABA) at the corresponding time (P < 0.05 and P < 0.01,
respectively). ⁄,⁄⁄Signiﬁcantly different from ‘‘without proadifen’’ at the corresponding time (P < 0.05 and P < 0.01, respectively).
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of phosphate buffered saline (PBS). Further centrifugation was per-
formed, and the precipitate was incubated for 15 min at 4 C with
200 lL of lysis buffer for the release of caspase 3, and 300 lL of PBS
was then added. The lysed cell suspension was centrifuged at
14,000g for 15 min at 4 C, and the supernatant was collected. Ali-
quots of 50 lL of supernatant were used to assess the activity of
caspase 3 according to the manufacturer’s instructions. Fluores-
cence was determined using the ﬂuorescence spectrophotometer
RF-5301 PC (Shimadzu, Tokyo, Japan) at wavelengths of 360 and
460 nm for excitation and emission, respectively. The results are
expressed as pmol of AMC/min/mL.
2.11. Necrotic cell death
Samples of cells (200 lL) were collected and centrifuged at 50g
for 5 min, and the precipitate was suspended in Krebs/Henseleit
medium, pH 7.4, and incubated with Hoechst 33342 (8 lg/mL)
and Propidium Iodide (5 lM) dyes for 15 min at room temperature
in the dark. After incubation, the samples were centrifuged twice at
50g for 5 min to remove excess dye. After the washes, the hepato-
cytes were suspended in 50 lL of Krebs/Henseleit medium, pH 7.4.
The cells were analyzed with a ﬂuorescence microscope (DM 2500
type, Leica, Rueil-Malmaison, France), and the percentage of necro-
tic cells was quantitated using the Qwin 3.0 software.2.12. Statistical analysis
Data are expressed as the mean ± standard error of the mean
(S.E.M.). The statistical signiﬁcance of the differences between con-
trol and the experimental groups was evaluated using one-way
analysis of variance (ANOVA) followed by Dunnett’s test, and dif-
ferences between the experimental groups at the same time points
was evaluated using unpaired t test with Welch´s correction. Values
of P < 0.05 were considered to be signiﬁcant. All statistical analyses
were performed using GraphPad Prism software, version 4.0 for
Windows (GraphPad Software, San Diego, CA, USA).
3. Results
3.1. Effects of ABA on the respiration of mitochondria in isolated rat
hepatocytes
Fig. 1 shows the inhibitory effect of ABA on the glutamate-
plus-malate-supported and succinate-supported state 3 (ADP-
stimulated) respiration of mitochondria in digitonin-permeabilized
hepatocytes. ABA has an inhibitory action on cellular respiration un-
der conditionswith the substrates of the respiratory chain complex I
(glutamate + malate) and with the substrate of complex II (succi-
nate) at the same concentrations and in a concentration-dependent
manner beginning at 5 lM. ABA did not stimulate state 4 (basal)
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Fig. 4. Effects of abamectin (ABA) on cell viability assessed by the release of the enzyme alanine transaminase (ALT) in isolated rat hepatocytes (106 cells/ml) in the absence or
presence of 100 lM proadifen (P). The results represent the mean ± SEM of six experiments with different cell preparations. #,##Signiﬁcantly different from control (without
ABA) at the corresponding time (P < 0.05 and P < 0.01, respectively). ⁄,⁄⁄Signiﬁcantly different from ‘‘without proadifen’’ at the corresponding time (P < 0.05 and P < 0.01,
respectively).
574 M.A. Maioli et al. / Toxicology in Vitro 27 (2013) 570–579respiration (results not shown). These results indicate that ABA
inhibits the oxidative phosphorylation of mitochondria as assessed
in isolated hepatocytes, and the results are in agreement with those
previously described that show ABA as an inhibitor of the adenine
nucleotide translocator (ANT) and FoF1-ATPase in isolated mito-
chondria (Castanha Zanoli et al., 2012). Proadifen (100 lM) did
not present any effect on the mitochondrial respiration of hepato-
cytes (results not shown).3.2. Effects of ABA on the mitochondrial membrane potential and ATP
levels in isolated rat hepatocytes
The effects of ABA on the mitochondrial membrane potential
and ATP levels were evaluated in the presence or absence of pro-
adifen, a cytochrome P450 inhibitor (Figs. 2 and 3, respectively).
The addition of increasing concentrations of ABA to the hepato-
cytes (25–100 lM) resulted in a decrease in the mitochondrial
membrane potential and ATP levels in a concentration- and time-
dependent manner. Proadifen stimulated an ABA-induced decrease
in the mitochondrial membrane potential and ATP levels (Figs. 2
and 3, respectively), suggesting that the parent drug by itself is
the main factor responsible for the toxic effect on isolated
hepatocytes.3.3. Effects of ABA on cell viability in isolated rat hepatocytes
The activity of ALT (Fig. 4) and AST (Fig. 5) was used to monitor
the viability of hepatocytes following exposure to different concen-
trations of ABA (25–100 lM) in the absence and presence of
proadifen.
The addition of increasing concentrations of ABA to hepatocytes
resulted in decreased cell viability, as assessed by ALT and AST
leakage into the incubation medium, in a concentration- and
time-dependent manner (Figs. 4 and 5, respectively). A signiﬁcant
increase in the concentration of ALT and AST was observed with
50 lM ABA at 90 min.
Proadifen stimulated the ABA-induced decrease in cell viability
because the cells showed a signiﬁcant release of both enzymes in
the presence of ABA (Figs. 4 and 5).3.4. Effects of ABA on intracellular Ca2+ homeostasis in isolated rat
hepatocytes
Intracellular Ca2+ homeostasis was evaluated by changes in the
ﬂuorescence probe Fura-2 in hepatocytes exposed to increasing
concentrations of ABA (25–100 lM) in the absence of proadifen
(Fig. 6).
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Fig. 5. Effects of abamectin (ABA) on cell viability assessed by the release of the enzyme aspartate transaminase (AST) in isolated rat hepatocytes (106 cells/ml) in the absence
or presence of 100 lM proadifen (P). The results represent the mean ± SEM of six experiments with different cell preparations. #,##Signiﬁcantly different from control
(without ABA) at the corresponding time (P < 0.05 and P < 0.01, respectively). ⁄,⁄⁄Signiﬁcantly different from ‘‘without proadifen’’ at the corresponding time (P < 0.05 and
P < 0.01, respectively).
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Fig. 6. Effects of abamectin (ABA) on intracellular Ca2+ homeostasis in isolated rat
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tion of 25 lM ABA and did not change following the addition of
higher concentrations (50, 75 and 100 lM) of the drug.3.5. Effects of ABA on cytochrome c release in isolated rat hepatocytes
The release of cytochrome c by the mitochondria was deter-
mined in hepatocytes exposed to increasing concentrations of
ABA (25–100 lM) in the absence of proadifen. The addition of
ABA to the incubation medium of hepatocytes did not result in a
signiﬁcant release of mitochondrial cytochrome c (results not
shown).3.6. Effects of ABA on caspase 3 activity in isolated rat hepatocytes
Caspase 3 activity was evaluated in hepatocytes previously
incubated with proadifen and exposed to increasing concentra-
tions of ABA (25–100 lM). However, the addition of ABA to the
incubation medium did not cause caspase 3 activation in hepato-
cytes throughout the experimental period (results not shown).3.7. Effects of ABA on the induction of necrotic cell death in isolated rat
hepatocytes
After 120 min of incubation, cell necrosis was evaluated by
Hoechst-propidium-iodide double staining in hepatocytes in the
absence or previously incubated with proadifen and exposed to
increasing concentrations of ABA (25–100 lM) (Fig. 7).
576 M.A. Maioli et al. / Toxicology in Vitro 27 (2013) 570–579ABA triggers cell death by necrosis in a concentration- and
time-dependent manner, becoming signiﬁcant at 60 min for con-
centrations of 75 and 100 lM (Bottom panel). Fifty micromolar
of ABA triggered necrosis after only 120 min of incubation. Proadi-
fen stimulated the ABA-induced cell necrosis.
4. Discussion
In this study, we used isolated rat hepatocytes to study the tox-
icity mechanism induced by ABA in vitro and the inﬂuence of bio-
transformation of the drug. The interference of ABA in the
functioning of the mitochondrial respiratory chain in isolated ratFig. 7. (Top panel) Representative ﬁgures showing the effects of abamectin (ABA) on cel
and propidium iodide. (A, B, C, D and E) 0, 25, 50, 75 and 100 lM ABA, respectively, at 0 m
50, 75 and 100 lM ABA, respectively, at 120 min, without proadifen, (K, L, M, N and O) 0,
Quantitation of necrotic cells expressed as the percentage of total cells counted. The
preparations in the absence or presence of 100 lM proadifen. #,##Signiﬁcantly differe
respectively). ⁄⁄Signiﬁcantly different from ‘‘without proadifen’’ at the corresponding timhepatocytes was monitored by measuring oxygen consumption.
The results showed a clear inhibition of the rate of oxygen con-
sumption in state 3 of mitochondrial respiration with both sub-
strates of complex I (glutamate + malate) and complex II
(succinate) at all of the tested concentrations (5–25 lM). These re-
sults are consistent with those obtained by Castanha Zanoli et al.
(2012), in which the effects of ABA on the isolated mitochondria
of rat liver were evaluated and an inhibitory effect on the ANT
and FoF1-ATPsintase was shown.
During the biotransformation of xenobiotics in the liver, the
metabolites generated can be even more toxic than the parent
compound (Ioannides and Lewis, 2004). In a study using rat liverl death by necrosis at 0 and 120 min as monitored by the ﬂuorescent dyes, Hoechst
in, representatives of experiments without or with proadifen, (F, G, H, I and J) 0, 25,
25, 50, 75 and 100 lM ABA, respectively, at 120 min, with proadifen. (Bottom panel)
results are shown as the mean ± S.E.M. of three experiments with different cell
nt from control (without ABA) at the corresponding time (P < 0.05 and P < 0.01,
e (P < 0.01).
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Fig. 7. (continued)
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produced from abamectin are 300-O-Desmethyl B1a (300-ODMe B1a),
24-Hydroxymethyl B1a (24 OHMe-B1a) and 26-Hydroxymethyl B1a
(26 OHMe-B1a). The authors attributed the metabolism of ABA to
cytochrome P450 isoforms 1A1 and 3A as responsible for the
metabolism of ABA, being the production of the metabolite 300-
ODMe B1a attributed to isoform 3A and the production of metabo-
lites 24 OHMe-B1a and 26-OHMe B1a to isoform 1A1.
Therefore, to evaluate the effect of the biotransformation on
ABA toxicity, the hepatocytes were incubated in the absence or
presence of proadifen, a broad inhibitor of cytochrome P450 iso-
forms (Khan et al., 1993; Bort et al., 1998; Mingatto et al., 2002;
Somchit et al., 2009; Shi et al., 2011), which was previously shown
to inhibit about 90% of the metabolism of ABA (Zeng et al., 1996).
ABA metabolism interferes with the mitochondrial membrane
potential because a more signiﬁcant decrease in this parameter
was observed in hepatocytes in the presence of proadifen. Due to
the inhibition of oxidative phosphorylation and the formation of
a mitochondrial membrane potential induced by ABA, a reduction
in the intracellular ATP concentration is expected. This effect was
observed in liver cells incubated with or without proadifen. The ef-
fect was more pronounced in the cells incubated with the P450
inhibitor, indicating that the parent drug is more toxic than the
metabolites.
Castanha Zanoli et al. (2012) observed an inhibitory effect of ABA
on the activity of ANT and FoF1-ATPase, thus blocking oxidative
phosphorylation. However, the researchers did not observe a de-crease in the mitochondrial membrane potential as was observed
in this study. A possible explanation for the dissipation in themem-
brane potential caused by ABA in isolated hepatocytes may be re-
lated to a loss of intracellular Ca2+ homeostasis (Skulachev, 1999).
When hepatocytes were exposed to 25 lMABA, a loss of intracellu-
lar ion homeostasis occurred. As the Ca2+ concentration increased in
the cell cytoplasm, themitochondria captured the surplus using the
uniporter (UP) channel. According to Brookes et al. (2004), the UP
ion uptake is dependent on the membrane potential, so the
movement of charges due to the uptake of calcium consumes the
membrane potential that was formed.
Furthermore, ABA-induced mitochondrial dysfunction reduces
cellular ATP levels and can promote in other organelles such
as endoplasmic reticulum, the inactivation of the pump respon-
sible for the maintenance of the Ca2+ ion gradient in the cyto-
plasm. Invariably, the result of inhibition of the transport
system is the disruption of intracellular calcium homeostasis.
The increase in intracellular Ca2+ can activate proteases,
phospholipases and ion-dependent endonucleases (Trump and
Berzesky, 1992).
The activation of proteases and phospholipases induces changes
in the cytoskeleton and plasma membrane. When combined, these
processes culminate in the disruption of cytoskeleton-plasma
membrane interactions, which results in destabilization of the lipid
bilayer, bleb formation on the cell surface and, in more severe
cases, leakage and cellular necrosis (Nicotera et al., 1986; Gores
et al., 1990; Sakaida et al., 1992).
Fig. 8. Schematic representation of the mechanisms of ABA-induced impairment of mitochondrial bioenergetics, disruption of calcium homeostasis and necrosis in isolated
rat hepatocytes.
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hepatic parenchymal cells (Klaassen and Eaton, 1991; Kaplowitz,
2001). According to Grisham (1979), an efﬂux of these enzymes
in the liquid incubation of cells in culture indicates that there
was a loss of membrane integrity. However, this efﬂux is not only
associated with cell death and lysis but also with modiﬁcations
that can be reversible (Grisham and Smith, 1984).
ABA increased the concentration of ALT and AST in the liquid
incubation of hepatocytes, and this effect was also inﬂuenced by
pre-incubation of the cells with proadifen. The changes observed
in the release of these enzymes may be a reﬂection of the inﬂuence
of ABA on mitochondrial activity. A decrease in the efﬁciency of en-
ergy production by the organelle affects cellular functions that are
dependent on energy, and the disruption of these functions may
result in cell death (Nicotera et al., 1998; Wallace and Starkov,
2000; Szewczyk and Wojtczak, 2002).
In in vivo studies performed by Lowenstein et al. (1996) and Hsu
et al. (2001), ABA caused an elevation in the concentration of the
AST in blood serum. El-Shenawy (2010) performed an in vitro study
with isolated rat hepatocytes to compare the toxic action of several
insecticides. Among the tested insecticides was ABA, which was
used at concentrations of 10 and 100 lM. The results obtained by
El-Shenawy (2010) showed a signiﬁcant increase in ALT and AST
leakage when the hepatocytes were incubated with 10 and
100 lM ABA for 30–120 min (ﬁnal period of sample collection).
Necrosis and apoptosis are types of cell death. One evident
physiological difference in cells undergoing apoptosis versus
necrosis is in the intracellular levels of ATP. Whereas necrotic cell
death occurs in the absence of ATP, apoptosis depends on intracel-
lular ATP levels (Tsujimoto, 1997). Many key events in apoptosis
focus on the mitochondria, including the release of caspase activa-
tors (such as cytochrome c), changes in electron transport, loss of
mitochondrial transmembrane potential, altered cellular oxida-
tion–reduction, and participation of pro- and antiapoptotic Bcl-2family proteins (Green and Reed, 1998). Thus, in this study, the
parameters related to both types of cell death were monitored,
allowing the type of cell death triggered by ABA in isolated hepa-
tocytes to be distinguished.
The release of cytochrome c and caspase 3 activity are steps in
determining apoptosis establishment for the intrinsic pathway
(Kass et al., 1996; Barros et al., 2003). For both parameters, we have
not found signiﬁcant variation in apoptosis induction in hepato-
cytes exposed to ABA.
Necrosis is characterized by changes that cause depletion of
ATP, disruption of ionic equilibrium, swelling of mitochondria
and the cell, and activation of degradative enzymes. These changes
result in the disruption of the plasma membrane and loss of
proteins, intracellular metabolites and ions (Eguchi et al., 1997;
Nicotera et al., 1998; Lemasters et al., 1999). Following microscopic
evaluation of Hoechst-propidium-iodide double staining, it was
conﬁrmed that ABA induces necrosis, which was initially observed
at 60 min in a concentration- and time-dependent manner upon
the addition of 75 and 100 lM of ABA and that proadifen stimu-
lated this effect.
This study indicates that the mechanism of ABA hepatotoxicity
involves an effect on mitochondrial bioenergetics and alteration in
calcium homeostasis, which leads to a decrease in ATP synthesis
with consequent cell death by necrosis (Fig. 8). Furthermore, this
study shows that the metabolism of ABA, which is performed by
cytochrome P450 in the liver, inﬂuences its toxicity. For all vari-
ables evaluated, there was an increase in the toxic potential of
ABA in the presence of proadifen, indicating that the parent drug
has greater potential than the metabolites.Conﬂict of interest statement
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